BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅
Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604 Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z , |
|
|
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅
Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604 Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z , |
|
|
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. ✅
Go to Publication ✅
The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604 Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z , |
|
|
Effect of Five Commercial Probiotic Formulations on Candida Albicans Growth: In Vitro Study. ✅
Go to Publication ✅
The Journal of clinical pediatric dentistry (J Clin Pediatr Dent ) Vol: 44 Issue 5 Pages: 315-322 Pub: 2020 Sep 1 Epub: Authors Hernández-Bautista LM , Márquez-Preciado R , Ortiz-Magdaleno M , Pozos-Guillén A , Aranda-Romo S , Sánchez-Vargas LO , |
|
|
The effect of synbiotics Bifidobacterium infantis and milk oligosaccharides on shaping gut microbiota community structure and NASH treatment. ✅
Go to Publication ✅
Data in brief (Data Brief ) Vol: 19 Issue Pages: 1025-1029 Pub: 2018 Aug Epub: 2018 May 24 Authors Jena PK , Sheng L , Nagar N , Wu C , Barile D , Mills DA , Wan YY , |
|
|
Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. ✅
Go to Publication ✅
BioMed research international (Biomed Res Int ) Vol: 2014 Issue Pages: 602832 Pub: 2014 Epub: 2014 May 22 Authors Rodes L , Saha S , Tomaro-Duchesneau C , Prakash S , |
|
|
Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. ✅
Go to Publication ✅
BioMed research international (Biomed Res Int ) Vol: 2014 Issue Pages: 602832 Pub: 2014 Epub: 2014 May 22 Authors Rodes L , Saha S , Tomaro-Duchesneau C , Prakash S , |
|
|
Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. ✅
Go to Publication ✅
BioMed research international (Biomed Res Int ) Vol: 2014 Issue Pages: 602832 Pub: 2014 Epub: 2014 May 22 Authors Rodes L , Saha S , Tomaro-Duchesneau C , Prakash S , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Anti-inflammatory effects of Bifidobacterium infantis M-63 during the early postnatal period in term infants. ✅
Go to Publication ✅
Pediatric research (Pediatr Res ) Vol: Issue Pages: Pub: 2025 Jul 18 Epub: 2025 Jul 18 Authors Xu C , Odamaki T , Hiraku A , Nakata S , Arai S , Iwabuchi N , Tanaka M , Tsuno T , Nakamura M , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
